Millipore Technical Publications |
 | BR- PB2697EN00 | |
Blood Typing Monoclonal AntibodiesBlood typing intermediates for further manufacturing use | ||
| Lit No: | PB2697EN00 | |
| Year: | 2009 | |
| Millipore, your partner for monoclonal blood typing antibodies For 25 years Millipore has been leading the development of monoclonal antibodies for the blood typing market. Millipore offers the largest stable of human IgM monoclonal antibodies available today and is still adding to its portfolio. Millipore’s brand is globally synonymous with quality. Our ISO certified and FDA licensed, state-of-the-art cGMP manufacturing facilities and experienced personnel enable us to stay in the forefront of this industry. Millipore’s blood typing intermediates for further manufacturing use (FFMU) are standardised cell culture supernatants from cell lines expressing human or murine monoclonal antibodies. These FFMU intermediates are for use in formulating finished blood typing reagents. By dilution, blending (where appropriate) and chemical additions, manufacturers can formulate their own finished reagents with reactivity profiles suitable for their specific applications. In many ways the Millipore range of FFMU intermediates is similar in usage to polyclonal source plasma. However the products have major advantages in lot-to-lot consistency—both in potency and specificity, and have minimal processing requirements—no defibrination, delipidisation or absorption of unwanted antibodies. The potency of each batch is carefully controlled to match that of an internal reference batch. All FFMUs contain 0.1% (w/v) sodium azide as a preservative. Click the PDF above for the full document. | |
| |
| |